- SEK43.76m
- SEK37.92m
Brief: Larkberget H1 Other Operating Income At SEK 100,000
Brief: Larkberget Estimates Nav Per Share At SEK 2.87 As Of July 9
Brief: Larkberget To Carry Out Rights Issue Of Units Totaling SEK 14.9 Mln
Brief: Larkberget Net Asset Value Per Share At SEK 3.04
Brief: Lärkberget Reports H2 Revenue Loss Of SEK 252,000
Brief: Larkberget Appoints Luca Di Stefano As CEO
Brief: Lärkberget Net Asset Value Per Share As Of Jan 15, 2025 Is SEK 3.08
Brief: Nasdaq Stockholm Removes Larkberget's Observation Status
Brief: Larkberget Invests SEK 50 Mln In Naxs AB
Brief: Larkberget H1 Net Sales Amounted To 252 Tsek
Brief: Combigene Appoints Robert Klatzkow As Chairman
Brief: Combigene Says Company Name Changed To Lärkberget
Brief: Combigene Informs About Proposed Strategic Changes In Co's Operations
Brief: Combigene Says Nasdaq Decides No New Listing Process Required For Combigene
Brief: Combigene To Change Name To Lärkberget
Brief: Combigene Q4 Sales SEK 0
Brief: Combigene Q4 Result After Financial Items Down To SEK -14,2 Mln
Brief: Combigene To Discontinue All Activities Linked To Research
Brief: CombiGene To Restructure, Terminate All Employment, Seek Partners